U.S. pharma large copyright scrapped two experimental weight loss pills final yr—a at the time-each day capsule, lotiglipron, as a consequence of elevated liver enzymes in addition to a 2 times-daily pill, danuglipron, due to robust Unwanted side effects—but CEO Albert Bourla has reported the company is determined to “Participate in and earn�